Pemetrexed and cisplatin is the name of a chemotherapy drug combination. It includes the drugs we list below, next to each drug we have how you pronounce the drug name in brackets. pemetrexed (peh-meh ...

People with ALK-positive lung cancer have much better outcomes with an established chemotherapy drug called pemetrexed (trade name: Alimta), new study suggests. A discovery at University of ...

LONDON (CBS.MW) -- Eli Lilly and Co. said its Alimta drug has been granted marketing authorization by the European Commission for two different indications. The product launch and availability of ...

Lilly also has sued two companies since June over its cancer drug Alimta, which has been its fastest-growing drug so far this year. And Lilly also is engaged in ongoing patent fights over five ...

That’s essentially what Eli Lilly and Co. has done with its newest and fastest-growing blockbuster, the lung cancer drug Alimta. In 2008, the Indianapolis-based company asked drug regulators to ...

Lilly said results of the phase-3 “PARAMOUNT” study of the injected drug Alimta (pemetrexed) extended progression-free survival in patients with nonsquamous nonsmall-cell lung cancer.

INDIANAPOLIS, Jan. 31, 2019 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) today announced that the U.S. Food and Drug Administration (FDA) has granted approval for a new indication for ALIMTA ...

In February 2004, pemetrexed disodium (Alimta; Eli Lilly), an anticancer drug that targets folate-dependent reactions that are essential for cell proliferation, became the first drug to be ...

Since its FDA approval, the drug, Alimta, has been a major success, stopping the growth of a variety of solid tumors while easing suffering and extending life. Taylor was recently the recipient of a ...

Eli Lilly & Co may have a $15 billion wild card up its sleeve as it waits for desperately needed new drugs to bear fruit.

ORLANDO, Fla. -- Eli Lilly & Co.'s experimental chemotherapy drug Alimta showed positive results in treating people suffering from a rare and insidious cancer caused by exposure to asbestos.

INDIANAPOLIS, June 5, 2018 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) today announced that the U.S. Food and Drug Administration (FDA) has ...